TARGETS

TARGETS Malaria

Over the past few decades, the number of malaria cases and deaths has soared. Today 3.2 billion people, more than half the world's population, are at risk of infection. There are between 350 million and 500 million clinical cases of malaria each year resulting in 1 million deaths.

80% (800,000) of those who die from Malaria are African children under the age of 5 years. The challenges are daunting as the mosquito and the parasite have proved themselves time and again to be resilient foes.

The TARGETS Consortium brings together a multidisciplinary team to investigate new malaria control technologies and strategies. Research on mosquito vector control tests new methods and products in laboratory and multi-village trials, and research includes a focus on the burden of disease in vulnerable groups such as children and women in pregnancy. Through this, the Consortium generates evidence and resources to inform public health policy debates and decisions at an international level.

• Download Targeting Malaria for more information about some of the RPC's projects and findings in malaria research